$axsm follow up

I received good follow up questions about $AXSM and its pricing strategy as a new novel drug in MDD vs traditional now generic serotonin drugs like Zoloft.  No doubt, the entire 20 million plus patient population is not moving to Auvelity tomorrow.  In fact, it never will.  The trajectory of the prescription ramp always takes time and education from KOL…